Riskpilot← Back to searchSign inGet full accessADDvance Pharma in Scandinavia AB
ABActiveOrg 5566415500Drottninggatan 13Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20032 employees
Revenue 2025
SEK 20,4M
-2% vs 2024
EBITDA margin
16.2%
-25% vs 2024
Equity ratio
50.3%
Financial strength
Net profit 2025
SEK 2,7M
-13% vs 2024
| Revenue | SEK 20,4M | -2% |
| EBITDA | SEK 3,3M | -25% |
| Net profit | SEK 2,7M | -13% |
| Total assets | SEK 13,5M | +9% |
| Equity | SEK 6,8M | -4% |
| Employees | 2 | — |
Legal name
ADDvance Pharma in Scandinavia AB
Org number
5566415500
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10 mars 2003
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva utveckling, produktion och försäljing av kosttillskott och naturläkemedel ävensom idka därmed förenlig verksamhet.
Address
Drottninggatan 13
Phone
+46706198443
Email
kim.hyllen@addvancepharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 13 183 | 13 588 | 20 185 | 20 879 | 20 409 |
| Staff expenses | — | — | −3 269 | — | — |
| EBITDA | 1 134 | 1 582 | 4 014 | 4 414 | 3 304 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 |
| EBIT | 1 134 | 1 582 | 4 014 | 4 414 | 3 304 |
| Net financials | −79 | −86 | 165 | 142 | 338 |
| Profit before tax | 105 | 326 | 1 139 | 3 977 | 3 421 |
| Tax | −100 | −6 | −254 | −848 | −687 |
| Net profit | 5 | 320 | 886 | 3 129 | 2 734 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 887 | 8 109 | 11 490 | 12 355 | 13 523 |
| Equity | 3 334 | 3 054 | 3 940 | 7 069 | 6 802 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 2 948 | 2 780 | 5 235 | 2 391 | 3 606 |
| Total debt | 2 948 | 2 780 | 5 235 | 2 391 | 3 606 |
EBITDA margin
16.2%
This company
15.8%
Market median
+3% vs market
20212025
Equity ratio
50.3%
This company
38.2%
Market median
+32% vs market
20212025
Return on equity
40.2%
This company
18.4%
Market median
+118% vs market
20212025
Net profit margin
13.4%
This company
8.1%
Market median
+65% vs market
20212025
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20212025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC Audit | Audit | 2022 |
| Former (1) | ||
HM Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bluegreen Holding AB
ADDvance Pharma in Scandinavia AB Board members of ADDvance Pharma in Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Christer Borg | Audit | 0 companies |
| Hanna Maria Ryttberg | Audit | 0 companies |
| Clara Josephine Hyllén | Deputy Board Member | 0 companies |
| Camilla Marianne Hyllén | Board of Directors | 0 companies |
| Linnea Carolina Hyllén | Deputy Board Member | 0 companies |
| Börje Allan Hyllén | Deputy Board Member | 0 companies |
| Kim Johan Hyllén | Chairman | 0 companies |